Evidence map›Paper›PMID 35169818›Full record

ArticlemedRxiv : the preprint server for health sciences2022

OraSure InteliSwab

Zachary A Weishampel, Janean Young, Mark Fischl, Robert J Fischer, Irene Owusu Donkor, Jade C Riopelle, Jonathan E Schulz, Julia R Port, Taylor A Saturday, Neeltje van Doremalen and 3 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Zachary A WeishampelLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Janean YoungOraSure Technologies Inc., Research and Development, Bethlehem, PA 18015, USA.
Mark FischlOraSure Technologies Inc., Research and Development, Bethlehem, PA 18015, USA.
Robert J FischerLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Irene Owusu DonkorLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Jade C RiopelleLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Jonathan E SchulzLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Julia R PortLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Taylor A SaturdayLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Neeltje van DoremalenLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Jody D BerryOraSure Technologies Inc., Research and Development, Bethlehem, PA 18015, USA.
Vincent J MunsterLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
Claude Kwe YindaLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, MT 59840, USA.
National Institute of Allergy and Infectious Diseases · USOrasure Technologies (United States) · USUniversity of Ghana · GH

Funding

Virus Ecology Unit - COVID-19 responseZIAAI001289 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MUNSTER, VINCENT · 2020 to 2025
$4.7M
6 · The paper itself

Abstract

The emergence of SARS-CoV-2 in the human population and the resulting COVID-19 pandemic has led to the development of various diagnostic tests. The OraSure InteliSwab

Identifiers

PMID35169818
PMCPMC8845516
OpenAlexW4210509564

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.